Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment

Tumor extracellular vesicles (EVs) demonstrate considerable promise for medication delivery and tumor targeting owing to their natural long-term blood circulation and tissue targeting capabilities. Researchers extracted EVs from mouse breast cancer cell 4T1 using UV stimulation and differential centrifugation. To create a new nano-drug delivery system, the vesicle delivery system (EPM) loaded with melanin and paclitaxel albumin (PA), the collected EVs were repeatedly compressed on a 200 nm porous polycarbonate membrane with melanin and PA. These findings suggest that EPM is readily absorbed by breast cancer and dendritic cells (DCs). EPM generates significant photoacoustic signals and photothermal effects when exposed to NIR light and can enhance the infiltration of CD8+ T cells in mouse tumor tissues. EPM is more cytotoxic than PA in in-vivo and in-vitro investigations. The efficacy of EPM in clinical transformation when paired with chemotherapy/photothermal/immunotherapy treatment is demonstrated in this study.

Bi Y, Chen J, Li Q, Li Y, Zhang L, Zhida L, Yuan F, Zhang R. (2023) Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment. iScience [Epub ahead of print]. [ abstract]

Leave a Reply

Your email address will not be published. Required fields are marked *

*